Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cyteir Therapeutics Q4 EPS $(0.25) Beats $(0.34) Estimate

Author: Michael Horton | March 23, 2023 03:20pm
Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.34) by 26.47 percent. This is a 26.47 percent increase over losses of $(0.34) per share from the same period last year.

Posted In: CYT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist